默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

交易中 04-26 12:48:01 EDT

131.15

+0.43

+0.33%

最高131.73	最低130.13	成交量334.77万
今开130.13	昨收130.72	日振幅1.22%
总市值3,322亿	流通市值3,316亿	总股本25.33亿
成交额4.39亿	换手率0.13%	流通股本25.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":131.15,"timestamp":1714150080497,"preClose":130.72,"halted":0,"volume":3347666,"delay":0,"floatShares":2528204036,"shares":2533028189,"eps":0.14,"marketStatus":"交易中","marketStatusCode":2,"change":0.43,"latestTime":"04-26 12:48:01 EDT","open":130.13,"high":131.73,"low":130.13,"amount":439234902.97246003,"amplitude":0.01224,"askPrice":131.19,"askSize":1,"bidPrice":131.15,"bidSize":10,"shortable":3,"etf":0,"ttmEps":0.14,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714161600000},"adr":0,"listingDate":-745790400000,"adjPreClose":130.72,"adrRate":0,"dividendRate":0.016698,"preHourTrading":{"tag":"盘前","latestPrice":130.61,"preClose":130.72,"latestTime":"09:29 EDT","volume":2017,"amount":263774.84911,"timestamp":1714138191062},"postHourTrading":{"tag":"盘后","latestPrice":130.89,"preClose":130.72,"latestTime":"19:59 EDT","volume":880223,"amount":115061750.9102,"timestamp":1714089573160},"volumeRatio":0.748386},"requestUrl":"/m/hq/s/MRK/wiki","defaultTab":"wiki","newsList":[{"id":"2430063682","title":"智飞生物多元化背后：摆脱默沙东HPV九价代理商的光环","url":"https://stock-news.laohu8.com/highlight/detail?id=2430063682","media":"观察者网","top":-1,"share":"https://www.laohu8.com/m/news/2430063682?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:08","pubTimestamp":1714140484,"startTime":"0","endTime":"0","summary":"过度依赖代理费，九价HPV疫苗竞争日趋激烈一直以来，“默沙东HPV九价疫苗中国唯一代理商”的光环闪耀于资本市场，然而，这一标签背后的业绩隐忧正逐渐显现。在财报公布后，4月23日，智飞生物股价一度暴跌超11%。这些新进入者将对智飞生物的市场份额构成严重威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262210237a563d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262210237a563d14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430501278","title":"艾伯维因 Skyrizi 销售强劲而上调年度利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430501278","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430501278?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:36","pubTimestamp":1714131396,"startTime":"0","endTime":"0","summary":"艾伯维和其投资者一直关注较新的免疫学药物Skyrizi和Rinvoq的销售情况，以抵消Humira对销售额的侵蚀--Humira是全球销量最大的药物，直到去年它失去了独家代理权，并出现了近似的仿制药。Skyrizi 的销售额为 20.1 亿美元，超过了预期的 19.4 亿美元，而 Rinvoq 的销售额为 10.9 亿美元，略高于预期的 10.6 亿美元。本季度，Humira 的销售额下降了近 36%，为 22.7 亿美元，与预期的 22.8 亿美元基本一致。本季度Imbruvica的销售收入为8.38亿美元，高于预期的7.44亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430269253","title":"隔夜美股全复盘(4.26)| Snap盘后一度飙升31%，Q1业绩和日活超预期，Q2指引好于预期；谷歌一度涨逾16%，首次宣布派息并至多回购700亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430269253","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2430269253?lang=zh_cn&edition=full","pubTime":"2024-04-26 07:43","pubTimestamp":1714088597,"startTime":"0","endTime":"0","summary":"Snap盘后一度飙升31%，Q1业绩和日活超预期，Q2指引好于预期；谷歌一度涨逾16%，首次宣布派息并至多回购700亿美元","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/724066","is_publish_highlight":false,"gpt_icon":0},{"id":"2430251458","title":"健康巡礼：新型疫苗或有助于阻止抗生素耐药菌的产生","url":"https://stock-news.laohu8.com/highlight/detail?id=2430251458","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430251458?lang=zh_cn&edition=full","pubTime":"2024-04-26 04:28","pubTimestamp":1714076938,"startTime":"0","endTime":"0","summary":"疫苗有助于解决抗生素耐药性问题研究人员利用一种新的疫苗开发方法，可能找到了解决抗生素耐药细菌问题的潜在办法。健康专家说，目前亟需新的抗生素或其他解决方案。要研制疫苗，研究人员必须找出一种会被人体视为外来物的分子。共有496名参与者接受了Keytruda治疗，498名参与者接受了安慰剂治疗。报告称，半数患者的随访时间超过了57个月，考虑到个体风险因素，Keytruda组患者在研究期间的死亡几率降低了38%。Keytruda的副作用发生率为20.7%，安慰剂为18.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430023287","title":"默沙东2023财年实现净利润3.65亿美元，同比减少97.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430023287","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430023287?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:22","pubTimestamp":1714065743,"startTime":"0","endTime":"0","summary":"12月31日，默沙东公布财报，公告显示公司2023财年净利润为3.65亿美元，同比减少97.49%；其中营业收入为598.71亿美元，同比增加2.39%，每股基本收益为0.14美元。从资产负债表来看，默沙东总负债690.40亿美元，其中短期债务16.57亿美元，资产负债比为0.01，流动比率为1.26。机构评级：截至2023年12月31日，当前有24家机构对默沙东目标价做出预测，其中目标均价为138.26美元，其中最低目标价为118.00美元，最高目标价为148.00美元。此外，默沙东还销售与动物健康相关的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260122338b53d879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260122338b53d879&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281406","title":"道指跌超600点，成分股IBM跌9.1%，默克制药仍然涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281406","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2430281406?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:59","pubTimestamp":1714053540,"startTime":"0","endTime":"0","summary":"格隆汇4月25日｜道指下跌超过650点，跌幅扩大至1.7%，成分股IBM跌9.1%，卡特彼勒跌8.5%，微软跌4.2%，亚马逊跌3.4%，迪士尼和陶氏化学至少跌2.6%，Salesforce、高盛、波音至多跌1.8%，苹果则涨超0.1%，英特尔涨0.5%，联合健康涨0.9%，可口可乐涨1.1%，默克制药涨3.4%“领跑”。纳指跌超2%，标普目前跌1.5%，半导体指数涨0.5%，费城银行指数跌1.5%。               \n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-25/doc-inatakpq5745359.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-25/doc-inatakpq5745359.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281582","title":"默沙东涨近4% Q1净利润同比增长69% 上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281582","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2430281582?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:43","pubTimestamp":1714052580,"startTime":"0","endTime":"0","summary":"格隆汇4月25日｜默沙东(MRK.US)涨3.93%，报131.99美元。默沙东第一季度全球销售总额158亿美元，同比增长9%；净利润47.62亿美元，同比增长69%。公司预计全年销售额区间为631亿至643亿美元，之前预测为627亿至642亿美元；非GAAP每股收益区间为8.53至8.65美元，高于之前预测的8.44至8.59美元。责任编辑：郭明煜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522100079237957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522100079237957&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430150285","title":"默克公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2430150285","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430150285?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:32","pubTimestamp":1714051965,"startTime":"0","endTime":"0","summary":"   * 默克公司公布的截至 3 月份的季度调整后每股收益为 2.07 美元，高于去年同期的每股收益 1.40 美元。18位分析师对该季度的平均预期为每股收益1.88美元。* 默克公司公布的本季度每股收益为 1.87 美元。* 公司季度净收入为 47.6 亿美元。* 默克公司本季度股价下跌了3.8%，今年迄今为止上涨了16.5%。4月25日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 5.9%。华尔街对默克公司 12 个月目标价的中位数为 139.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430021324","title":"疫苗龙头，没了2800亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2430021324","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2430021324?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:25","pubTimestamp":1714047925,"startTime":"0","endTime":"0","summary":"高光不再","market":"hk","thumbnail":"https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/d4adc-abc3c929-b511-4371-8478-b21853917ecb.png?guru_height=546&guru_width=707"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/723988","is_publish_highlight":false,"gpt_icon":0},{"id":"2430240449","title":"默沙东(MRK.US)畅销抗癌药Keytruda销售额激增20% 上调全年EPS预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2430240449","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430240449?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:06","pubTimestamp":1714046793,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，4月25日美股盘前，美国医药巨头默沙东公布最新业绩，该公司上调年度利润和总营收预期，其重磅抗癌药物Keytruda继续在癌症治疗领域占据绝对的主导地位。财报数据显示，默沙东抗癌药物Keytruda的第一季度销售额同比增长20%，至69亿美元，高于分析师普遍预期的67亿美元的平均水平。据了解，默沙东于2021年以110亿美元收购Acceleron Pharma Inc.，成功获得该药物。默沙东还表示，三阴性乳腺癌和肾癌以及其他肿瘤患者们对Keytruda药物的需求持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110430.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430424621","title":"Hipgnosis 的竞购战愈演愈烈，Concord 提高了对夏奇拉音乐所有者的报价","url":"https://stock-news.laohu8.com/highlight/detail?id=2430424621","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430424621?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:47","pubTimestamp":1714031221,"startTime":"0","endTime":"0","summary":"Hipgnosis 的股价上涨了 1.1%，报 1.028 英镑，因为新的出价刺激了全球最大的私募股权公司提出更高反价的前景。Concord 上周 ，同意以每股 1.16 美元的价格收购音乐版权投资基金，但上周末 Blackstone 出价高于 Concord。Concord 的出价是正式出价，而 Blackstone 尚未提出确定的出价，或宣布有意按照英国收购规则提出正式出价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430442878","title":"科伦博泰生物-B(06990)：年报首秀营收增92%，默沙东合作产品7款在研","url":"https://stock-news.laohu8.com/highlight/detail?id=2430442878","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430442878?lang=zh_cn&edition=full","pubTime":"2024-04-25 12:31","pubTimestamp":1714019460,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B 在业绩上也展现出显著的进步。此外，调整后年内亏损额降至4.51亿元，同比减少了24.4%。值得注意的是，科伦博泰生物-B 与制药巨头默沙东的合作进展顺利，已有7款产品处于合作进程中。2023年，公司从默沙东处获得了首付款及里程碑款项，总额达14.21亿元，占公司年内营收的92.27%。据国联证券分析，科伦博泰生物-B 目前在国内外的临床试验布局均取得了显著进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251311318b51838a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251311318b51838a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430417534","title":"港股异动 | 科伦博泰生物-B(06990)涨超6% 背靠默沙东23年营收大涨 SKB264有望成泛癌种显著获益的ADC大单品","url":"https://stock-news.laohu8.com/highlight/detail?id=2430417534","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430417534?lang=zh_cn&edition=full","pubTime":"2024-04-25 10:11","pubTimestamp":1714011099,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科伦博泰生物-B涨超6%，截止发稿涨6.04%，报163.3港元，成交额2002万港元。业绩方面，3月25日公司发布了上市以来的首份年报。据悉目前科伦博泰与默沙东共有7款处于合作进程中的产品。基于上述合作，2023年，科伦博泰共从默沙东处获取了14.21亿元的首付款及里程碑款项，占公司年内营收的92.27%。此外，科伦博泰SKB264目前正在全球范围内开展针对多个瘤种的单药/联用的Ⅱ期和Ⅲ期临床试验，有望成为泛癌种显著获益的ADC大单品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109521.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430941661","title":"重庆富豪蒋仁生，年内没了300亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2430941661","media":"雷达财经","top":-1,"share":"https://www.laohu8.com/m/news/2430941661?lang=zh_cn&edition=full","pubTime":"2024-04-25 08:37","pubTimestamp":1714005461,"startTime":"0","endTime":"0","summary":"据此计算，年内蒋仁生身家缩水312.65亿元。直到46岁，蒋仁生扔掉“铁饭碗”，成为了一名疫苗销售员。如果分季度来看，智飞生物在2023年第四季度的营业收入为136.46亿元，同比增长30.70%，归母净利润为15.40亿元，同比下降20.3%。2023年1月29日，智飞生物公告将继续独家代理默沙东HPV疫苗、五价轮状病毒疫苗等产品，协议期限至2026年12月31日，协议产品基础采购金额合计超过1000亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8Z3vVAsaNsW","is_publish_highlight":false,"gpt_icon":0},{"id":"2430629524","title":"BUZZ-前瞻：默克公司有望公布第一季度每股收益和营收增长报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2430629524","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430629524?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:34","pubTimestamp":1713983664,"startTime":"0","endTime":"0","summary":"    4月24日 - ** 默克公司  股价在周四开盘前公布季报前上涨0.2%。** 根据LSEG的最新数据，华尔街认为MRK的每股收益为1.88美元，去年同期为1.40美元，收入为15.196美元，同比增长4.9%。** 在过去的 8 个季度中，默克公司的每股收益和营业收入均超过了一致预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430462500","title":"未来一天的看点 - 4月25日星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2430462500","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430462500?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:30","pubTimestamp":1713983434,"startTime":"0","endTime":"0","summary":"美国劳工部的每周失业救济申请数据可能会显示，在截至4月20日的一周内，各州首次申请失业救济的人数增加了3000人，经季节性因素调整后为215000人。与此同时，首次领取失业救济金的人数可能从截至4月13日当周的181.2万人降至180.5万人。美国航空公司将公布第一季度财报。由于主要市场需求低迷，陶氏预计将公布第一季度收入下降的报告。烟草巨头 Altria 将公布第一季度业绩。受客户转向广告流媒体的帮助，Roku 第一季度收入预计将增长 14.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429758781","title":"业绩飘红后股价大跌 智飞生物“绑定”默沙东的喜与忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2429758781","media":"贝壳财经","top":-1,"share":"https://www.laohu8.com/m/news/2429758781?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:40","pubTimestamp":1713922821,"startTime":"0","endTime":"0","summary":"4月23日，智飞生物股价报收35.39元/股，跌11.99%。前一日，公司发布2023年年报。尽管年内交出营收、利润双增的答卷，但公司股价却出现大跌。一方面，2023年业绩飘红背后，智飞生物毛利率较高的自主产品收入下滑，公司营收主要靠代理产品带动，但该类产品毛利率在年内进一步下降，公司盈利空间收窄。与此同时，连年增长的销...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OeUnBamt_93tAxwlI_fLdFUrMgIAwVhCqGVZA0s0csV9AAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OeUnBamt_93tAxwlI_fLdFUrMgIAwVhCqGVZA0s0csV9AAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240424A01RMC00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240424A01RMC00","is_publish_highlight":false,"gpt_icon":0},{"id":"2429734192","title":"默克公司  预计每股收益1.88美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429734192","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429734192?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:19","pubTimestamp":1713878379,"startTime":"0","endTime":"0","summary":"   * 默克公司将于4月25日公布截至2024年3月31日的业绩报告，预计该公司的季度收入将有所增长。* LSEG 分析师对默克公司的平均预期为每股收益 1.88 美元。* 华尔街对默克公司 12 个月目标价的中位数为 139.00 美元，高于其上次收盘价 126.94 美元。4月23日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429987287","title":"Seagen、BMS和默沙东狙击的新兴赛道，诺奖得主入局","url":"https://stock-news.laohu8.com/highlight/detail?id=2429987287","media":"动脉vcbeat","top":-1,"share":"https://www.laohu8.com/m/news/2429987287?lang=zh_cn&edition=full","pubTime":"2024-04-21 08:00","pubTimestamp":1713657600,"startTime":"0","endTime":"0","summary":"经营一家生物技术初创公司需要多少成本？从实验室租金的预算到专家学者的薪酬，似乎很难找到有关早期生物技术成本的数据，也没有一个普遍适用的数字或公式。毕竟，每家公司在开发阶段、产品类型、市场规模、竞争环境以及合作伙伴等方面都存在着巨大的差异。研发任务究竟需要多少预算？建立科学顾问委员会（SAB）又应该预留...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/O9OB-lwWDoC311PgAVU5oeYAruA_MSI0jwwFMxFhm4wuIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O9OB-lwWDoC311PgAVU5oeYAruA_MSI0jwwFMxFhm4wuIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240421A00W6B00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240421A00W6B00","is_publish_highlight":false,"gpt_icon":0},{"id":"2428597554","title":"坎托菲茨杰拉德公司：重申Merck & Co(MRK.US)评级，由增持调整至增持评级, 目标价135.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428597554","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428597554?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:06","pubTimestamp":1713449163,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Merck & Co(MRK.US)评级，由增持调整至增持评级, 目标价135.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182206068790b2a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182206068790b2a8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":0.0414},{"period":"3month","weight":0.0819},{"period":"6month","weight":0.2713},{"period":"1year","weight":0.1524},{"period":"ytd","weight":0.199}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018848},{"month":5,"riseRate":0.659091,"avgChangeRate":0.019791},{"month":6,"riseRate":0.522727,"avgChangeRate":0.013252},{"month":7,"riseRate":0.5,"avgChangeRate":0.00548},{"month":8,"riseRate":0.477273,"avgChangeRate":0.000646},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.005533},{"month":10,"riseRate":0.545455,"avgChangeRate":0.021263},{"month":11,"riseRate":0.727273,"avgChangeRate":0.029373},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}